AN2 Therapeutics Inc. Common Stock (ANTX)
About The Company
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
IPO Year | Sector | Industry |
---|---|---|
2022 | Health Care | Biotechnology: Pharmaceutical Preparations |
AN2 Therapeutics Inc. (ANTX) Latest News
Company Contact & Address (ANTX)
Corporate Headquarters | Phone | Website |
---|---|---|
1800 EL CAMINO REAL SUITE D, MENLO PARK, California, 94027, United States |
+1 650 331-9090 | Official ANTX Website |
ANTX Key Executives
Ownership and management information.
Key Data Points*
Exchange | Not Available | Market Cap | Not Available |
---|---|---|---|
Sector | Health Care | P/E Ratio | Not Available |
Industry | Biotechnology: Pharmaceutical Preparations | Forward P/E 1 Yr. | Not Available |
1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
Today’s High/Low | Not Available | Annualized Dividend | Not Available |
Share Volume | Not Available | Ex Dividend Date | Not Available |
Average Volume | Not Available | Dividend Pay Date | Not Available |
Previous Close | Not Available | Current Yield | Not Available |
52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ ANTX
Jobs & Employment at AN2 Therapeutics Inc.
LinkedIn Company Page | https://www.linkedin.com/company/an2-therapeutics-inc |
---|---|
Official Career & Employment Page | See LinkedIn page for more employment & jobs details. |
Related & Similar Stock Symbols
![]() MFVMFS Special Value Trust Common Stock
|
![]() TIGTrean Insurance Group Inc. Common Stock
|
![]() ADRTAult Disruptive Technologies Corporation Common Stock
|